Jim Frates

Jim Frates

Finansdirektör/CFO på AMYLYX PHARMACEUTICALS, INC.

Förmögenhet: 5 M $ per 2026-06-30

58 år
Consumer Services
Commercial Services
Health Technology

Profil

Mr. James M.
Frates
is a Chief Financial Officer at Amylyx Pharmaceuticals, Inc. He is on the Board of Directors at St. Francis House.
Mr. Frates was previously employed as an Independent Director by SAGE Therapeutics, Inc., a National Director by The Association of Bioscience Financial Officers, a Chief Financial Officer & Senior Vice President by Alkermes Plc, a Vice President-Investment Banking by Robertson Stephens & Co., a Treasurer & Trustee by Roxbury Latin School, and a Treasurer & Trustee by St. Paul's School.
He also served on the board at GPC Biotech AG.
He received his undergraduate degree from Harvard College and an MBA from Harvard Business School.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-04-10 261 628 ( 0,24 % ) 5 M $ 2026-06-30

Aktiva positioner av Jim Frates

FöretagPositionStart
AMYLYX PHARMACEUTICALS, INC. Finansdirektör/CFO 2021-01-01
Direktör/Styrelseledamot -

Tidigare kända positioner av Jim Frates

FöretagPositionSlut
SAGE THERAPEUTICS, INC. Direktör/Styrelseledamot 2025-07-31
ALKERMES PLC Finansdirektör/CFO 2021-01-11
Direktör/Styrelseledamot 2009-06-01
Direktör/Styrelseledamot 2009-01-01
Företagsledare/Principal 1998-06-01
Se detaljerna i Jim Fratess erfarenhet

Jim Fratess utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

76

Första gradens relationer

11

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag11

Commercial Services

Finance

Commercial Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

  1. Börsen
  2. Insiders
  3. Jim Frates